GlucoTrack (NASDAQ:GCTK) Posts Earnings Results

GlucoTrack (NASDAQ:GCTK) posted its quarterly earnings results on Friday. The company reported $0.76 earnings per share for the quarter, FiscalAI reports.

GlucoTrack Trading Up 0.5%

GCTK stock opened at $0.37 on Friday. GlucoTrack has a 52 week low of $0.25 and a 52 week high of $14.14. The company has a market capitalization of $2.84 million, a PE ratio of -0.04 and a beta of 0.70. The company’s 50-day simple moving average is $0.40 and its 200 day simple moving average is $0.88. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.85 and a current ratio of 0.85.

Institutional Trading of GlucoTrack

A number of institutional investors have recently bought and sold shares of GCTK. Bank of America Corp DE grew its position in shares of GlucoTrack by 102,125.0% during the 2nd quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock worth $25,000 after purchasing an additional 4,085 shares in the last quarter. Boothbay Fund Management LLC acquired a new stake in shares of GlucoTrack in the fourth quarter valued at approximately $52,000. Finally, Ikarian Capital LLC acquired a new stake in shares of GlucoTrack in the fourth quarter valued at approximately $177,000. Institutional investors own 10.92% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on GCTK. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of GlucoTrack in a research report on Friday, July 17th. Wall Street Zen raised shares of GlucoTrack from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 8th. One analyst has rated the stock with a Sell rating, According to MarketBeat, GlucoTrack currently has an average rating of “Sell”.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.